Pheochromocytoma and paraganglioma: Diagnosis, genetics, management, and treatment

2014/01/01 by Victoria Martucci, Victoria L. Martucci, Karel Pacak +1 · 1 citation
Medicine · #Adrenal and Paraganglionic Tumors #Hormonal Regulation and Hypertension #Pituitary Gland Disorders and Treatments

paper · pdf · doi:10.1016/j.currproblcancer.2014.01.001

crossref issued 2014/01/01 · crossref published 2014/01/01 · crossref published-print 2014/01/01 · openalex publication_date 2014/01/01 · crossref created 2014/01/15 · crossref deposited 2024/05/23 · openalex created_date 2025/10/10 · crossref indexed 2026/06/10 · openalex updated_date 2026/07/22

Citations

• Germline Mutations and Variants in the Succinate Dehydrogenase Genes in Cowden and Cowden-like Syndromes
• Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC–PGL syndromes: a clinicopathological and molecular analysis
• The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
• VEGF in 105 pheochromocytomas: enhanced expression correlates with malignant outcome
• Tumor risks and genotypeâphenotypeâproteotype analysis in 358 patients with germline mutations inSDHBandSDHD
• Are we overestimating the penetrance of mutations in SDHB?
• Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis
• SDHA is a tumor suppressor gene causing paraganglioma

Cited by

• Adrenal gland [wikipedia]